As US da­ta for Covid-19 vac­cine loom, As­traZeneca cleans house and scraps sev­er­al asth­ma, can­cer drugs from pipeline

Just a week af­ter re­veal­ing an­oth­er flop for its PD-1/CT­LA-4 strat­e­gy, As­traZeneca has scrapped plans for the Imfinzi/treme­li­mum­ab com­bo in head and neck can­cer. …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER